On Biostatistics and Clinical Trials

CQ's web blog on the issues in biostatistics and clinical trials.

Friday, March 11, 2011

Use of SF-36 in Clinical Trials

›
The SF-36 is a multi-purpose, short-form health survey with 36 questions. SF-36 is one of the most popular instruments for generic health su...
4 comments:
Thursday, March 03, 2011

Incidence Rate (IR) – How could this be wrongly calculated?

›
I am very surprised to see how a simple concept of ‘incidence rate’ can be wrongly calculated in documents  submitted to regulatory agencies...
7 comments:
Friday, February 25, 2011

Study Center Pooling Strategy in Multicenter Clinical Trials

›
Pooling the study center for statistical analysis purpose is rather an old issue. However, we can still see the discussion o f study center ...
6 comments:
Tuesday, February 08, 2011

Guidelines for Blood Volumes in Clinical Trials (Especially in Pediatric Clinical Trials)

›
Nowadays, the clinical study protocols are becoming more and more complicated and require more and more blood sample draws for various purpo...
4 comments:
Friday, January 28, 2011

Edit check - a critical step to ensure the data quality during clincial trials

›
In clinical trial, one critical task is to ensure that the data collected or data entered into the system / database is valid, correct, and ...
11 comments:
Sunday, January 23, 2011

Regulatory Guidance on Source Data in EDC Trials

›
When we move toward the clinical studies using electronic data capture, the ‘source data’ or ‘source document’ has been an issue. Unlike the...
1 comment:
Tuesday, January 11, 2011

FDA's New Website for Industry

›
Have you noticed the changes in the design of FDA website ( http://www.fda.gov/ ) recently? Last August, I mentioned the FDA's initiati...
Sunday, January 02, 2011

Agreement Statistics and Kappa

›
In clinical trial and medical research, we often have a situation where two different measures/assessments are performed on the same sample,...
2 comments:
Monday, December 27, 2010

Bootstrap and SAS

›
In statistics, bootstrapping is a resampling technique used to obtain estimates of summary statistics. In clinical trials, bootstrapping te...
2 comments:
Sunday, December 12, 2010

Counting the study day

›
For every clinical trial, we need to count the study day for calculating the follow-up visits and for assessing the temporal relationship...
4 comments:
Monday, November 29, 2010

A conditional probability issue?

›
There is a question and answer from 'AskMarilyn' at Parade.com . I copy the question and answer here since it is a probability issue...
4 comments:
Saturday, November 20, 2010

Using RevMan to Conduct the Meta Analysis

›
RevMan (or Review Manager) is designed as a review tool to facilitate the literature review and the meta analyses by the Cochrane Collaborat...
11 comments:
Sunday, November 07, 2010

Good Review Practice

›
In previous article, 'regulatory science' is discussed. 'Good Review Practice' can be considered one aspect of the regulator...
Sunday, October 31, 2010

Regulatory Science

›
Regulatory Science is the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and perform...
Friday, October 08, 2010

Missing data in clinical trials - the new guideline from EMEA and National Academies

›
Missing data issues have been discussed and debated for many years. Handling of missing data in clinical trials has been recognized as an im...
4 comments:
Sunday, October 03, 2010

Individual response vs. group response

›
In clinical trials, the efficacy endpoints are often measured as continuous variables. The hypothesis tests are used to determine whether or...
Sunday, September 26, 2010

Do we really need to statistical soluation for everything?

›
I came back from last week's FDA/Industry Statistics Workshop with more questions than answers. While the theme for this year's wor...
Sunday, September 19, 2010

Number of Events vs. Number of Subjects with Events

›
Often in clinical trial safety data analysis, people are confused with the basic concept of "number of events" vs "number of ...
4 comments:
Sunday, September 12, 2010

Restricted randomization, stratified randomization, and forced randomization

›
Randomization is a fundamental aspect of randomized controlled trials (RCT) . When we judge a quality of a clinical trial, whether or not it...
1 comment:
Sunday, September 05, 2010

Immunogenicity and its impact in clinical trials

›
There is a shift in drug development field from the chemical compounds to the biological products - protein products and a shift from tradit...
‹
›
Home
View web version

About Me

My photo
Web blog from Dr. Deng
Chapel Hill, NC, United States
邓春勤 A Medical Doctor turned into Biostatistician in Clinical Trial and Drug Development Industry
View my complete profile
Powered by Blogger.